A comprehensive molecular interaction map for rheumatoid arthritis

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Wu, Gang ^a   Zhu, Lisha ^a   Dent, Jennifer E ^a   Nardini, Christine ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADALIMUMAB; AZATHIOPRINE; BUCILLAMINE; CANERTINIB; CETUXIMAB; CISPLATIN; CRK LIKE PROTEIN; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; ETANERCEPT; GEFITINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; LAPATINIB; METHOTREXATE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN FOS; PROTEIN KINASE B BETA; PROTEIN MDM2; PROTEIN P53; RAC1 PROTEIN; RAC2 PROTEIN; RAF PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR NFAT; UNINDEXED DRUG;

ACCESS TO INFORMATION; ARTICLE; COMPUTER MODEL; COMPUTER PROGRAM; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; INTERNET; MEDICAL RESEARCH; MOLECULAR INTERACTION; PATIENT CARE; PROTEIN MOTIF; PROTEIN TARGETING; RHEUMATOID ARTHRITIS; TISSUE SPECIFICITY; BIOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; METABOLISM; PROTEIN ANALYSIS; SYSTEMS BIOLOGY;

ARTHRITIS, RHEUMATOID; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; PROTEIN INTERACTION MAPPING; SYSTEMS BIOLOGY;

EID: 77956300684     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010137     Document Type: Article

References (123)

1. Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 american college of rheumatology criteria: a systematic review. Semin Arthritis Rheum 36: 182-188.
2. Schneider M, Manabile E, Tikly M (2008) Social aspects of living with rheumatoid arthritis: a qualitative descriptive study in soweto, south africa - a low resource context. Health Qual Life Outcomes 6: 54-54.
3. Giladi H, Sukenik S, Flusser D, Liel-Cohen N, Applebaum A, et al. (2008) A rare case of enterobacter endocarditis superimposed on a mitral valve rheumatoid nodule. J Clin Rheumatol 14: 97-100.
4. Carl HD, Swoboda B (2008) [Effectiveness of arthroscopic synovectomy in rheumatoid arthritis]. Z Rheumatol 67: 485-490.
5. Meltzer EB, Noble PW (2008) Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 3: 8-8.
6. Levin J, Werth VP (2006) Skin disorders with arthritis. Best Pract Res Clin Rheumatol 20: 809-826.
7. Eyre S, Hinks A, Flynn E, Martin P, Wilson AG, et al. (2009) Confirmation of association of the rel locus with rheumatoid arthritis susceptibility in the uk population. Ann Rheum Dis.
8. van der Linden MP, Feitsma AL, le Cessie S, Kern M, Olsson LM, et al. (2009) Association of a single-nucleotide polymorphism in cd40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum 60: 2242-2247.
9. Wu CC, Shete S, Chen WV, Peng B, Lee AT, et al. (2009) Detection of diseaseassociated deletions in case-control studies using snp genotypes with application to rheumatoid arthritis. Hum Genet 126: 303-315.
10. van Baarsen LG, Bos CL, van der Pouw Kraan TC, Verweij CL (2009) Transcription profiling of rheumatic diseases. Arthritis Res Ther 11: 207-207.
11. Toonen EJ, Barrera P, Radstake TR, van Riel PL, Scheffer H, et al. (2008) Gene expression profiling in rheumatoid arthritis: current concepts and future directions. Ann Rheum Dis 67: 1663-1669.
12. Pohlers D, Beyer A, Koczan D, Wilhelm T, Thiesen HJ, et al. (2007) Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 9.
13. Koczan D, Drynda S, Hecker M, Drynda A, Guthke R, et al. (2008) Molecular discrimination of responders and nonresponders to anti-tnf alpha therapy in rheumatoid arthritis by etanercept. Arthritis Res Ther 10.
14. Hammaker D, Sweeney S, Firestein GS (2003) Signal transduction networks in rheumatoid arthritis. Ann Rheum Dis 62 Suppl 2: 86-89.
15. Sweeney SE, Firestein GS (2004) Signal transduction in rheumatoid arthritis. Curr Opin Rheumatol 16: 231-237.
16. Morel J, Berenbaum F (2004) Signal transduction pathways: new targets for treating rheumatoid arthritis. Joint Bone Spine 71: 503-510.
17. Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, et al. (2008) Altered expression of microrna in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 58: 1001-1009.
18. Funahashi A, Morohashi M, Kitano H, Tanimura N (2003) Celldesigner: a process diagram editor for gene-regulatory and biochemical networks. BIOSILICO 1: 159-162.
19. Klipp E, Liebermeister W, Helbig A, Kowald A, Schaber J (2007) Systems biology standards?the community speaks. Nature Biotechnology. pp 390-391.
20. Holt RA, Jones SJ (2008) The new paradigm of flow cell sequencing. Genome Res 18: 839-846.
21. Wang Z, Gerstein M, Snyder M (2009) Rna-seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10: 57-63.
22. Lea P, Keystone E, Mudumba S, Kahama A, Ding SF, et al. (2009) Advantages of multiplex proteomics in clinical immunology: The case of rheumatoid arthritis: Novel igxplex: Planar microarray diagnosis. Clin Rev Allergy Immunol.
23. Sha N, Vannucci M, Brown PJ, Trower MK, Amphlett G, et al. (2003) Gene selection in arthritis classification with large-scale microarray expression profiles. Comp Funct Genomics 4: 171-181.
24. Arranz A, Gutiérrez-Cañas I, Carrión M, Juarranz Y, Pablos JL, et al. (2008) Vip reverses the expression profiling of tlr4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts. Mol Immunol 45: 3065-3073.
25. Sekiguchi N, Kawauchi S, Furuya T, Inaba N, Matsuda K, et al. (2008) Messenger ribonucleic acid expression profile in peripheral blood cells from ra patients following treatment with an anti-tnf-alpha monoclonal antibody, infliximab. Rheumatology (Oxford) 47: 780-788.
26. Nakamura C, Matsushita I, Kosaka E, Kondo T, Kimura T (2008) Antiarthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells. Rheumatology (Oxford) 47: 418-424.
27. Qingchun H, Runyue H, LiGang J, Yongliang C, Song W, et al. (2008) Comparison of the expression profile of apoptosis-associated genes in rheumatoid arthritis and osteoarthritis. Rheumatol Int 28: 697-701.
28. Andreas K, Lübke C, Häupl T, Dehne T, Morawietz L, et al. (2008) Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study. Arthritis Res Ther 10.
29. Auer J, Bläss M, Schulze-Koops H, Russwurm S, Nagel T, et al. (2007) Expression and regulation of ccl18 in synovial fluid neutrophils of patients with rheumatoid arthritis. Arthritis Res Ther 9.
30. Timmer TC, Baltus B, Vondenhoff M, Huizinga TW, Tak PP, et al. (2007) Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum 56: 2492-2502.
31. Zer C, Sachs G, Shin JM (2007) Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-alpha signaling. Physiol Genomics 31: 343-351.
32. Galligan CL, Baig E, Bykerk V, Keystone EC, Fish EN (2007) Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity. Genes Immun 8: 480-491.
33. Devauchelle V, Marion S, Cagnard N, Mistou S, Falgarone G, et al. (2004) Dna microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun 5: 597-608.
34. Lindberg J, af Klint E, Catrina AI, Nilsson P, Klareskog L, et al. (2006) Effect of infliximab on mrna expression profiles in synovial tissue of rheumatoid arthritis patients. Arthritis Res Ther 8.
35. Lequerré T, Gauthier-Jauneau AC, Bansard C, Derambure C, Hiron M, et al. (2006) Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis. Arthritis Res Ther 8.
36. Julià A, Barceló M, Erra A, Palacio C, Marsal S (2009) Identification of candidate genes for rituximab response in rheumatoid arthritis patients by microarray expresion profiling in blood cells. Pharmacogenomics 10: 1697-1708.
37. Olsen N, Sokka T, Seehorn CL, Kraft B, Maas K, et al. (2004) A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann Rheum Dis 63: 1387-1392.
38. Lequerré T, Bansard C, Vittecoq O, Derambure C, Hiron M, et al. (2009) Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia. Arthritis Res Ther 11.
39. Alsaleh G, Suffert G, Semaan N, Juncker T, Frenzel L, et al. (2009) Bruton's tyrosine kinase is involved in mir-346-related regulation of il-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes. J Immunol 182: 5088-5097.
40. Junta CM, Sandrin-Garcia P, Fachin-Saltoratto AL, Mello SS, Oliveira RD, et al. (2009) Differential gene expression of peripheral blood mononuclear cells from rheumatoid arthritis patients may discriminate immunogenetic, pathogenic and treatment features. Immunology 127: 365-372.
41. Edwards CJ, Feldman JL, Beech J, Shields KM, Stover JA, et al. (2007) Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Mol Med 13: 40-58.
42. Silva GL, Junta CM, Mello SS, Garcia PS, Rassi DM, et al. (2007) Profiling meta-analysis reveals primarily gene coexpression concordance between systemic lupus erythematosus and rheumatoid arthritis. Ann N Y Acad Sci 1110: 33-46.
43. van der Pouw Kraan T, Wijbrandts C, van Baarsen L, Rustenburg F, Baggen J, et al. (2008) Responsiveness to anti-tumour necrosis factor {alpha} therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients. British Medical Journal 67: 563.
44. van der Pouw Kraan T, van Gaalen F, Kasperkovitz P, Verbeet N, Smeets T, et al. (2003) Rheumatoid arthritis is a heterogeneous disease. Arthritis Rheum 48: 2132-2145.
45. Oki K, Tsuji F, Ohashi K, Kageyama M, Aono H, et al. (2009) The investigation of synovial genomic targets of bucillamine with microarray technique. Inflamm Res 58: 571-584.
46. Teixeira VH, Olaso R, Martin-Magniette ML, Lasbleiz S, Jacq L, et al. (2009) Transcriptome analysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid arthritis patients. PLoS One 4.
47. Kalatzis FG, Giannakeas N, Exarchos TP, Lorenzelli L, Adami A, et al. (2009) Developing a genomic-based point-of-care diagnostic system for rheumatoid arthritis and multiple sclerosis. Conf Proc IEEE Eng Med Biol Soc 1: 827-830.
48. Ziober AF, Patel KR, Alawi F, Gimotty P, Weber RS, et al. (2006) Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clin Cancer Res 12: 5960-5971.
49. Alberghina L, Hofer T, Vanoni M (2009) Molecular networks and system-level properties. Journal of Biotechnology.
50. Barrenas F, Chavali S, Holme P, Mobini R, Benson M (2009) Network properties of complex human disease genes identified through genome-wide association studies. PLoS ONE 4: e8090.
51. Sengupta U, Ukil S, Dimitrova N, Agrawal S (2009) Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications. PLoS ONE 4: e8100.
52. Lu R, Markowetz F, Unwin RD, Leek JT, Airoldi EM, et al. (2009) Systemslevel dynamic analyses of fate change in murine embryonic stem cells. Nature 462: 358-362.
53. Eschrich S, Zhang H, Zhao H, Boulware D, Lee JH, et al. (2009) Systems biology modeling of the radiation sensitivity network: A biomarker discovery platform. International Journal of Radiation Oncology Biology Physics 75: 497-505.
54. Reka A (2005) Scale-free networks in cell biology. J Cell Sci 118: 4947-4957.
55. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabasi AL (2000) The large-scale organization of metabolic networks. Nature 407: 651-654.
56. Newman MEJ, Barabasi AL, Watts DJ, eds (2006) The Structure and Dynamics of Networks Princeton University Press.
57. Barabasi AL (2009) Scale-free networks: A decade and beyond. Science 325: 412-413.
58. Vallabhajosyula RR, Chakravarti D, Lutfeali S, Ray A, Raval A (2009) Identifying hubs in protein interaction networks. PLoS ONE 4: e5344
59. JACOB F, PERRIN D, SANCHEZ C, MONOD J (1960) [Operon: a group of genes with the expression coordinated by an operator.]. C R Hebd Seances Acad Sci 250: 1727-1729.
60. Brandman O, Meyer T (2008) Feedback loops shape cellular signals in space and time. Science 322: 390-395.
61. Klein TE, Chang JT, Cho MK, Easton KL, Fergerson R, et al. (2001) Integrating genotype and phenotype information: an overview of the pharmgkb project. pharmacogenetics research network and knowledge base. Pharmacogenomics J 1: 167-170.
62. Murakami M, Sasaki T, Yamasaki S, Kuwahara K, Miyata H, et al. (2004) Induction of apoptosis by ionizing radiation and ci-1033 in hucct-1 cells. Biochem Biophys Res Commun 319: 114-119.
63. Pander J, Gelderblom H, Guchelaar HJ (2007) Pharmacogenetics of egfr and vegf inhibition. Drug Discov Today 12: 1054-1060.
64. Glaysher S, Yiannakis D, Gabriel FG, Johnson P, Polak ME, et al. (2009) Resistance gene expression determines the in vitro chemosensitivity of nonsmall cell lung cancer (nsclc). BMC Cancer 9: 300-300.
65. Ji L, Roth JA (2008) Tumor suppressor fus1 signaling pathway. J Thorac Oncol 3: 327-330.
66. Amano Y, Lee SW, Allison AC (1993) Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mrna stability. Mol Pharmacol 43: 176-182.
67. Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M, et al. (1992) Glucocorticoids downregulate gene expression of gm-csf, nap-1/il-8, and il-6, but not of m-csf in human fibroblasts. Blood 79: 45-51.
68. Huang J, Sun Y, Huang XY (2004) Distinct roles for src tyrosine kinase in beta2-adrenergic receptor signaling to mapk and in receptor internalization. J Biol Chem 279: 21637-21642.
69. Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, et al. (2004) Bay 43-9006 exhibits broad spectrum oral antitumor activity and targets the raf/mek/erk pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 64: 7099-7109.
70. Poppe D, Tiede I, Fritz G, Becker C, Bartsch B, et al. (2006) Azathioprine suppresses ezrin-radixin-moesin-dependent t cell-apc conjugation through inhibition of vav guanosine exchange activity on rac proteins. J Immunol 176: 640-651.
71. Black AJ, McLeod HL, Capell HA, Powrie RH, Matowe LK, et al. (1998) Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med 129: 716-718.
72. Li JC, Kaminskas E (1984) Accumulation of dna strand breaks and methotrexate cytotoxicity. Proc Natl Acad Sci USA 81: 5694-5698.
73. Lorico A, Toffoli G, Boiocchi M, Erba E, Broggini M, et al. (1988) Accumulation of dna strand breaks in cells exposed to methotrexate or n10-propargyl-5,8-dideazafolic acid. Cancer Res 48: 2036-2041.
74. Nelson WG, Kastan MB (1994) Dna strand breaks: the dna template alterations that trigger p53-dependent dna damage response pathways. Mol Cell Biol 14: 1815-1823.
75. Sabio G, Das M, Mora A, Zhang Z, Jun JY, et al. (2008) A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322: 1539-1543.
76. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat Protoc 4: 44-57.
77. Ohashi K, Burkart V, Flohé S, Kolb H (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164: 558-561.
78. Sacre SM, Andreakos E, Kiriakidis S, Amjadi P, Lundberg A, et al. (2007) The toll-like receptor adaptor proteins myd88 and mal/tirap contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol 170: 518-525.
79. Joosten LA, Koenders MI, Smeets RL, Heuvelmans-Jacobs M, Helsen MM, et al. (2003) Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88. J Immunol 171: 6145-6153.
80. Liacini A, Sylvester J, Li WQ, Huang W, Dehnade F, et al. (2003) Induction of matrix metalloproteinase-13 gene expression by tnf-alpha is mediated by map kinases, ap-1, and nf-kappab transcription factors in articular chondrocytes. Exp Cell Res 288: 208-217.
81. Suzuki M, Tetsuka T, Yoshida S, Watanabe N, Kobayashi M, et al. (2000) The role of p38 mitogen-activated protein kinase in il-6 and il-8 production from the tnf-alpha- or il-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett 465: 23-27.
82. Schett G, Tohidast-Akrad M, Smolen JS, Schmid BJ, Steiner CW, et al. (2000) Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-jun n-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 43: 2501-2512.
83. Shiozawa S, Tsumiyama K (2009) Pathogenesis of rheumatoid arthritis and cfos/ap-1. Cell Cycle 8: 1539-1543.
84. Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, et al. (2000) Forkhead transcription factor fkhr-l1 modulates cytokine-dependent transcriptionl regulation of p27(kip1). Mol Cell Biol 20: 9138-9148.
85. Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ (2000) Expression of the pro-apoptotic bcl-2 family member bim is regulated by the forkhead transcription factor fkhr-l1. Curr Biol 10: 1201-1204.
86. Ludikhuize J, de Launay D, Groot D, Smeets TJ, Vinkenoog M, et al. (2007) Inhibition of forkhead box class o family member transcription factors in rheumatoid synovial tissue. Arthritis Rheum 56: 2180-2191.
87. Kuo CC, Lin SC (2007) Altered foxo1 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients. Mol Med 13: 561-566.
88. Singh K, Colmegna I, He X, Weyand CM, Goronzy JJ (2008) Synoviocyte stimulation by the lfa-1-intercellular adhesion molecule-2-ezrin-akt pathway in rheumatoid arthritis. J Immunol 180: 1971-1978.
89. Parker A, Izmailova ES, Narang J, Badola S, Le T, et al. (2007) Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate. J Rheumatol 34: 1817-1822.
90. Hodgkinson CP, Ye S (2008) Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression. Pharmacogenet Genomics 18: 803-813.
91. Coenen MJ, Toonen EJ, Scheffer H, Radstake TR, Barrera P, et al. (2007) Pharmacogenetics of anti-tnf treatment in patients with rheumatoid arthritis. Pharmacogenomics 8: 761-773.
92. Kooloos WM, de Jong DJ, Huizinga TW, Guchelaar HJ (2007) Potential role of pharmacogenetics in anti-tnf treatment of rheumatoid arthritis and crohn's disease. Drug Discov Today 12: 125-131.
93. Mehindate K, al Daccak R, Rink L, Mecheri S, Hebert J, et al. (1994) Modulation of mycoplasma arthritidis-derived superantigen-induced cytokine gene expression by dexamethasone and interleukin-4. Infect Immun 62: 4716-4721.
94. Nishida K, Komiyama T, Miyazawa S, Shen ZN, Furumatsu T, et al. (2004) Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16ink4a and p21(waf1/cip1) expression. Arthritis Rheum 50: 3365-3376.
95. Lacroix BD, Lovern MR, Stockis A, Sargentini-Maier ML, Karlsson MO, et al. (2009) A pharmacodynamic markov mixed-effects model for determining the effect of exposure to certolizumab pegol on the acr20 score in patients with rheumatoid arthritis. Clin Pharmacol Ther 86: 387-395.
96. Tolusso B, Pietrapertosa D, Morelli A, De Santis M, Gremese E, et al. (2006) Il-1b and il-1rn gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Pharmacogenomics 7: 683-695.
97. Nurse P (1990) Universal control mechanism regulating onset of m-phase. Nature 344: 503-508.
98. Kawasaki H, Komai K, Nakamura M, Yamamoto E, Ouyang Z, et al. (2003) Human wee1 kinase is directly transactivated by and increased in association with c-fos/ap-1: rheumatoid synovial cells overexpressing these genes go into aberrant mitosis. Oncogene 22: 6839-6844.
99. Shiozawa S, Shiozawa K, Fujita T (1983) Morphologic observations in the early phase of the cartilage-pannus junction. light and electron microscopic studies of active cellular pannus. Arthritis Rheum 26: 472-478.
100. Fassbender HG (1984) Is pannus a residue of inflammation? Arthritis Rheum 27: 956-957.
101. Fassbender HG (1998) What destroys the joint in rheumatoid arthritis? Arch Orthop Trauma Surg 117: 2-7.
102. Handel ML, McMorrow LB, Gravallese EM (1995) Nuclear factor-kappa b in rheumatoid synovium. localization of p50 and p65. Arthritis Rheum 38: 1762-1770.
103. Benito MJ, Murphy E, Murphy EP, van den Berg WB, FitzGerald O, et al. (2004) Increased synovial tissue nf-kappa b1 expression at sites adjacent to the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum 50: 1781-1787.
104. Han Z, Boyle DL, Manning AM, Firestein GS (1998) Ap-1 and nf-kappab regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28: 197-208.
105. Atreya I, Atreya R, Neurath M (2008) NF-kappaB in inflammatory bowel disease. J Intern Med 263: 591-596.
106. De Bosscher K, Berghe V, et al. (2003) The interplay between the glucocorticoid receptor and nuclear factor-{kappa} B or activator protein-1: molecular mechanisms for gene repression. Endocrine reviews 24: 488.
107. van der Heijden IM, Wilbrink B, Tchetverikov I, Schrijver IA, Schouls LM, et al. (2000) Presence of bacterial dna and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 43: 593-598.
108. Radstake TR, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PL, et al. (2004) Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum 50: 3856-3865.
109. Brentano F, Schorr O, Gay RE, Gay S, Kyburz D (2005) Rna released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll-like receptor 3. Arthritis Rheum 52: 2656-2665.
110. Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, et al. (2003) Expression and regulation of toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol 16: 1221-1227.
111. Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, van Lieshout AW, Sprong T, et al. (2005) The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 52: 2313-2322.
112. Brentano F, Kyburz D, Schorr O, Gay R, Gay S (2005) The role of toll-like receptor signalling in the pathogenesis of arthritis. Cell Immunol 233: 90-96.
113. Jeong H, Mason SP, Barabási AL, Oltvai ZN (2001) Lethality and centrality in protein networks. Nature 411: 41-42.
114. Albert R, Jeong H, Barabasi AL (2000) Error and attack tolerance of complex networks. Nature 406: 378-382.
115. Wuchty S, Almaas E (2005) Peeling the yeast protein network. Proteomics 5: 444-449.
116. Zhu M, Gao L, Li X, Liu Z (2009) Identifying drug-target proteins based on network features. Sci China C Life Sci 52: 398-404.
117. Smithgall TE (1995) Sh2 and sh3 domains: potential targets for anti-cancer drug design. J Pharmacol Toxicol Methods 34: 125-132.
118. Birge RB, Kalodimos C, Inagaki F, Tanaka S (2009) Crk and crkl adaptor proteins: networks for physiological and pathological signaling. Cell Commun Signal 7: 13-13.
119. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Research 13: 2498-2504.
120. Calzone L, Gelay A, Zinovyev A, Radvanyl F, Barillot E (2008) A comprehensive modular map of molecular interactions in rb/e2f pathway. Mol Syst Biol 4.
121. Zinovyev A, Viara E, Calzone L, Barillot E (2008) BiNoM: a Cytoscape plugin for manipulating and analyzing biological networks. Bioinformatics 24: 876-877.
122. Vismara P (1997) Union of all the minimum cycle bases of a graph. URL http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.47.3674.
123. Assenov Y, Ramirez F, Schelhorn SE, Lengauer T, Albrecht M (2008) Computing topological parameters of biological networks. Bioinformatics 24: 282-284.